E. I. Dmitrieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. I. Dmitrieva has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anzhella Zh. Fursova
Novosibirsk Regional Clinical Hospital; Novosibirsk State Medical University
7 shared publications - Anna S. Derbeneva
Novosibirsk Regional Clinical Hospital; Novosibirsk State Medical University
6 shared publications - I. F. Nikulich
Novosibirsk Regional Clinical Hospita; Novosibirsk State Medical University
5 shared publications - Maria A. Vasilyeva
Novosibirsk Regional Clinical Hospital; Novosibirsk State Medical University
5 shared publications - M. S. Tarasov
Novosibirsk Regional Clinical Hospita; Novosibirsk State Medical University
4 shared publications - O. G. Gusarevich
Novosibirsk State Medical University
4 shared publications
Latest Publications
- Open Access
- 13 July 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 45 (3) , 161-171
Comprehensive evaluation of cataract phacoemulsification surgery efficacy in patients with neovascular age-related macular degeneration treated by of antiangiogenic drugs
The aim of the study is a comprehensive assessment (including the patient’s opinion) of the impact of cataract phacoemulsification on the state of visual functions, morphological biomarkers of disease activity in patients with neovascular age-related macular degeneration (nAMD) against the background of antiangiogenic therapy. Material and methods. The study included individuals with nAMD and cataract; the main group included 117 patients (117 eyes) (age 76.2 ± 5.7 years, arithmetic mean ± standard deviation), and the control group included 96 people (96 eyes) (age 77,01 ± 6,02 years). All patients received angiogenesis inhibitor therapy (aflibercept 2 mg), in Treat&Extend regimen, patients in control group – after phacoemulsification. In the main group, phacoemulsification was performed under the condition of monitoring disease activity. A questionnaire including 10 questions was developed to interview patients, 9 of which were assessed before, 1 and 6 months after phacoemulsification, and a 10th question on patient satisfaction with the results of surgery – 1 and 6 months after cataract surgery. Results. The number of injections was 6.85 ± 1.78 before surgery, 7.85 ± 0.83 in the first year with a subsequent decrease to 7.04 ± 1.50 and 3.85 ± 1.22 in the second and third years, respectively; the interval between injection was prolonged accordingly (to 13.35 ± 1.84 weeks by the third year). In 100 % of eyes, there was a significant improvement in best-corrected visual acuity with an absolute increase from pre-surgery baseline to the end of follow-up by 0.28 (from 0.22 ± 0.17 to 0.50 ± 0.18). Positive dynamics of the central retinal thickness reduction (by 138.5 μm, 36.5 %) was noted in comparison with value at the beginning of therapy, as well as neuro- and pigment epithelium detachment throughout the entire observation period. Statistically significant correlations of best-corrected visual acuity, number of injections, and interval between injections with morphologic biomarkers of nAMD activity were found throughout the follow-up. There was a significant improvement in patients’ assessment of vision-related quality of life. The most compromised aspect before surgery was the ability to read text in newspapers, books, and magazines. After surgery there was a significant improvement of the indicators characterizing the patient’s adaptation to navigation and outside activities. 99 patients (84.0 %) reported satisfaction with the results of the surgery. Conclusions. Cataract surgery and continuation of antiangiogenic therapy of nAMD based on MNV activity are accompanied by a reduction in the number of intravitreal injections and contribute to the positive dynamics of functional and anatomical parameters in the short and long term, which is of clinical value to the physician and has an important impact on the daily functioning of the patient.
- 13 July 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 45 (3) , 161-171
Open AccessComprehensive evaluation of cataract phacoemulsification surgery efficacy in patients with neovascular age-related macular degeneration treated by of antiangiogenic drugs
The aim of the study is a comprehensive assessment (including the patient’s opinion) of the impact of cataract phacoemulsification on the state of visual functions, morphological biomarkers of disease activity in patients with neovascular age-related macular degeneration (nAMD) against the background of antiangiogenic therapy. Material and methods. The study included individuals with nAMD and cataract; the main group included 117 patients (117 eyes) (age 76.2 ± 5.7 years, arithmetic mean ± standard deviation), and the control group included 96 people (96 eyes) (age 77,01 ± 6,02 years). All patients received angiogenesis inhibitor therapy (aflibercept 2 mg), in Treat&Extend regimen, patients in control group – after phacoemulsification. In the main group, phacoemulsification was performed under the condition of monitoring disease activity. A questionnaire including 10 questions was developed to interview patients, 9 of which were assessed before, 1 and 6 months after phacoemulsification, and a 10th question on patient satisfaction with the results of surgery – 1 and 6 months after cataract surgery. Results. The number of injections was 6.85 ± 1.78 before surgery, 7.85 ± 0.83 in the first year with a subsequent decrease to 7.04 ± 1.50 and 3.85 ± 1.22 in the second and third years, respectively; the interval between injection was prolonged accordingly (to 13.35 ± 1.84 weeks by the third year). In 100 % of eyes, there was a significant improvement in best-corrected visual acuity with an absolute increase from pre-surgery baseline to the end of follow-up by 0.28 (from 0.22 ± 0.17 to 0.50 ± 0.18). Positive dynamics of the central retinal thickness reduction (by 138.5 μm, 36.5 %) was noted in comparison with value at the beginning of therapy, as well as neuro- and pigment epithelium detachment throughout the entire observation period. Statistically significant correlations of best-corrected visual acuity, number of injections, and interval between injections with morphologic biomarkers of nAMD activity were found throughout the follow-up. There was a significant improvement in patients’ assessment of vision-related quality of life. The most compromised aspect before surgery was the ability to read text in newspapers, books, and magazines. After surgery there was a significant improvement of the indicators characterizing the patient’s adaptation to navigation and outside activities. 99 patients (84.0 %) reported satisfaction with the results of the surgery. Conclusions. Cataract surgery and continuation of antiangiogenic therapy of nAMD based on MNV activity are accompanied by a reduction in the number of intravitreal injections and contribute to the positive dynamics of functional and anatomical parameters in the short and long term, which is of clinical value to the physician and has an important impact on the daily functioning of the patient.
- Open Access
- 14 December 2024
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 17 (4) , 55-61
Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration
Purpose. To study of the effectiveness of cataract surgery based on the results of a comprehensive evaluation, including the patient's opinion about the state of visual functions, when assessed using a questionnaire before and after surgery.Material and methods. 117 patients (117 eyes) diagnosed with nAMD and cataract (LOCS I — 56 patients, 47.9 %; LOCS II — 57 patients, 48.7 %, LOCS III — 4 patients, 3.4 %), mean age 76.2 ± 5.7 years were included in the study. All patients received angiogenesis inhibitor therapy (aflibercept 2 mg), in Treat&Extend regimen. Cataract surgery was performed if disease activity is controlled. A questionnaire including 10 questions was developed to interview patients, 9 of which were assessed before, 1 and 6 months after cataract surgery, and a 10th question on patient satisfaction with the results of surgery — 1 and 6 months after cataract surgery.Results. There was a significant improvement in functional (increase in BCVA by 0.31 units from the baseline) and anatomical parameters (significant decrease in CRT, height of neuro- and pigment epithelium detachment), as well as in patients' assessment of vision-related quality of life. The most compromised aspect before surgery was the ability to read text in newspapers, books, and magazines. After surgery there was a significant improvement of the indicators characterizing the patient's adaptation to navigation and outside activities. There were minimal changes in central vision loss and metamorphopsia as assessed by patients (on average, by 0.02 b. and 1.21 b.). 99 patients (84.0 %) reported satisfaction with the results of the surgery. The strongest correlations (r = 0.94 and 0.81, p < 0.05) characterized the relationship between patients' evaluation of the effect of surgery and the presence of central vision spotting/loss of central vision, double vision.Conclusion. The results of surgery significantly contribute to the patient's assessment of his/her daily activities requiring clearer vision, primarily in the middle and far distances. Cataract surgery does not worsen the course of nAMD and, on the contrary, cataract surgery and continuation of antiangiogenic therapy contribute to a significant improvement in BCVA and anatomical improvement.
- 14 December 2024
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 17 (4) , 55-61
Open AccessEvaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration
Purpose. To study of the effectiveness of cataract surgery based on the results of a comprehensive evaluation, including the patient's opinion about the state of visual functions, when assessed using a questionnaire before and after surgery.Material and methods. 117 patients (117 eyes) diagnosed with nAMD and cataract (LOCS I — 56 patients, 47.9 %; LOCS II — 57 patients, 48.7 %, LOCS III — 4 patients, 3.4 %), mean age 76.2 ± 5.7 years were included in the study. All patients received angiogenesis inhibitor therapy (aflibercept 2 mg), in Treat&Extend regimen. Cataract surgery was performed if disease activity is controlled. A questionnaire including 10 questions was developed to interview patients, 9 of which were assessed before, 1 and 6 months after cataract surgery, and a 10th question on patient satisfaction with the results of surgery — 1 and 6 months after cataract surgery.Results. There was a significant improvement in functional (increase in BCVA by 0.31 units from the baseline) and anatomical parameters (significant decrease in CRT, height of neuro- and pigment epithelium detachment), as well as in patients' assessment of vision-related quality of life. The most compromised aspect before surgery was the ability to read text in newspapers, books, and magazines. After surgery there was a significant improvement of the indicators characterizing the patient's adaptation to navigation and outside activities. There were minimal changes in central vision loss and metamorphopsia as assessed by patients (on average, by 0.02 b. and 1.21 b.). 99 patients (84.0 %) reported satisfaction with the results of the surgery. The strongest correlations (r = 0.94 and 0.81, p < 0.05) characterized the relationship between patients' evaluation of the effect of surgery and the presence of central vision spotting/loss of central vision, double vision.Conclusion. The results of surgery significantly contribute to the patient's assessment of his/her daily activities requiring clearer vision, primarily in the middle and far distances. Cataract surgery does not worsen the course of nAMD and, on the contrary, cataract surgery and continuation of antiangiogenic therapy contribute to a significant improvement in BCVA and anatomical improvement.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (6) , 7-14
Analysis of the effectiveness of cataract surgery in neovascular age-related macular degeneration
Purpose. This study evaluated the impact of phacoemulsification cataract surgery (PE) on anatomical and functional parameters, as well as the regimen and frequency of anti-VEGF injections in patients with neovascular age-related macular degeneration (nAMD) over a long-term period (up to 3 years). Material and Methods. The study included 117 patients (117 eyes) diagnosed with nAMD and cataract, graded by LOCS: LOCS I (n=56; 47.9%), LOCS II (n=57; 48.7%), LOCS III (n=4; 3.4%); the average age of the patients was 76.2±5.7 years. All patients received anti-VEGF therapy (aflibercept 2 mg) following the treat-and-extend protocol. PE was performed only with disease activity under control. The observation period included 12 months before PE and 36 months after, with eight checkpoints for standard ophthalmological examination. Results. The average number of injections before PE was 6.85±1.78. In the first year after PE, the injection frequency increased to 7.85±0.83, then decreased to 7.04±1.50 in the second year and 3.85±1.22 in the third, with intervals between injections lengthening (to 13.35±1.84 weeks by the third year). All eyes (100%) demonstrated significant improvement in best-corrected visual acuity (BCVA), with an absolute increase of 0.28 from pre-PE baseline (from 0.22±0.17 to 0.50±0.18 by study end). There was a positive trend in reduction of central retinal thickness (by 138.5 μm or 36.5%) compared to baseline at the start of treatment, as well as reduction in neuroretinal and retinal pigment epithelial detachment over the observation period. Statistically significant correlations were found between BCVA, injection frequency, injection interval, and morphological biomarkers of nAMD activity over time. Conclusion. Initiation of antiangiogenic therapy in nAMD patients and the continuation of individualized monitoring and treatment after PE is associated with effective suppression of nAMD activity, improvement in functional and anatomical parameters, and a reduction in the number of intravitreal injections both in the short term and the long term.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (6) , 7-14
Analysis of the effectiveness of cataract surgery in neovascular age-related macular degeneration
Purpose. This study evaluated the impact of phacoemulsification cataract surgery (PE) on anatomical and functional parameters, as well as the regimen and frequency of anti-VEGF injections in patients with neovascular age-related macular degeneration (nAMD) over a long-term period (up to 3 years). Material and Methods. The study included 117 patients (117 eyes) diagnosed with nAMD and cataract, graded by LOCS: LOCS I (n=56; 47.9%), LOCS II (n=57; 48.7%), LOCS III (n=4; 3.4%); the average age of the patients was 76.2±5.7 years. All patients received anti-VEGF therapy (aflibercept 2 mg) following the treat-and-extend protocol. PE was performed only with disease activity under control. The observation period included 12 months before PE and 36 months after, with eight checkpoints for standard ophthalmological examination. Results. The average number of injections before PE was 6.85±1.78. In the first year after PE, the injection frequency increased to 7.85±0.83, then decreased to 7.04±1.50 in the second year and 3.85±1.22 in the third, with intervals between injections lengthening (to 13.35±1.84 weeks by the third year). All eyes (100%) demonstrated significant improvement in best-corrected visual acuity (BCVA), with an absolute increase of 0.28 from pre-PE baseline (from 0.22±0.17 to 0.50±0.18 by study end). There was a positive trend in reduction of central retinal thickness (by 138.5 μm or 36.5%) compared to baseline at the start of treatment, as well as reduction in neuroretinal and retinal pigment epithelial detachment over the observation period. Statistically significant correlations were found between BCVA, injection frequency, injection interval, and morphological biomarkers of nAMD activity over time. Conclusion. Initiation of antiangiogenic therapy in nAMD patients and the continuation of individualized monitoring and treatment after PE is associated with effective suppression of nAMD activity, improvement in functional and anatomical parameters, and a reduction in the number of intravitreal injections both in the short term and the long term.
- 29 December 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (6) , 50-58
Prognosis criteria of optical coherence tomography angiography for the long-term efficacy of anti-VEGF therapy of neovascular age-related macular degeneration
PURPOSE The study aimed to determine the most significant optical coherence tomography angiography (OCTA) parameters in terms of predicting anti-VEGF therapy effectiveness during long-term (3-year) follow-up of patients with neovascular age-related macular degeneration (nAMD). MATERIAL AND METHODS The study included 122 patients (122 eyes) with mean age of 73.4±6.6 years who were diagnosed with nAMD. Subgroup analysis included 50 patients (50 eyes) with detailed OCT angiography examination of macular neovascularization (MNV) characteristics and their changes in the course of the follow-up, which lasted 144 weeks. All patients were treated by angiogenesis inhibitor (aflibercept 2 mg), most of them — according to Treat-and-Extend protocol. RESULTS Treatment response (either ‘good’ or ‘partial’) was achieved in all patients, and the proportion of the response types was similar in both types 1 and 2 MNV. Key OCTA parameters associated with the number of injections, as well as morphological and functional response (best-corrected visual acuity, retinal neuroepithelium and pigment epithelium detachment), were vascular network area and MNV area assessed at baseline and three months after treatment initiation. Both of these parameters were closely related in both MNV types during the follow-up. Key parameter with maximum number of clinically significant correlations (‘very high’ strength, p<0.05) in eyes with ‘good’ response was MNV area, in eyes with ‘partial’ response — vascular density and greatest vascular caliber. CONCLUSIONS Vascular network area and MNV area assessed at baseline and after three loading doses were determined as the most significant OCTA characteristics for predicting the number of injections and treatment response based on functional and morphological parameters. MNV area was found to be the most clinically significant marker in ‘good’ response, vascular density and greatest vascular caliber — in ‘partial’ response.
- 29 December 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (6) , 50-58
Prognosis criteria of optical coherence tomography angiography for the long-term efficacy of anti-VEGF therapy of neovascular age-related macular degeneration
PURPOSE The study aimed to determine the most significant optical coherence tomography angiography (OCTA) parameters in terms of predicting anti-VEGF therapy effectiveness during long-term (3-year) follow-up of patients with neovascular age-related macular degeneration (nAMD). MATERIAL AND METHODS The study included 122 patients (122 eyes) with mean age of 73.4±6.6 years who were diagnosed with nAMD. Subgroup analysis included 50 patients (50 eyes) with detailed OCT angiography examination of macular neovascularization (MNV) characteristics and their changes in the course of the follow-up, which lasted 144 weeks. All patients were treated by angiogenesis inhibitor (aflibercept 2 mg), most of them — according to Treat-and-Extend protocol. RESULTS Treatment response (either ‘good’ or ‘partial’) was achieved in all patients, and the proportion of the response types was similar in both types 1 and 2 MNV. Key OCTA parameters associated with the number of injections, as well as morphological and functional response (best-corrected visual acuity, retinal neuroepithelium and pigment epithelium detachment), were vascular network area and MNV area assessed at baseline and three months after treatment initiation. Both of these parameters were closely related in both MNV types during the follow-up. Key parameter with maximum number of clinically significant correlations (‘very high’ strength, p<0.05) in eyes with ‘good’ response was MNV area, in eyes with ‘partial’ response — vascular density and greatest vascular caliber. CONCLUSIONS Vascular network area and MNV area assessed at baseline and after three loading doses were determined as the most significant OCTA characteristics for predicting the number of injections and treatment response based on functional and morphological parameters. MNV area was found to be the most clinically significant marker in ‘good’ response, vascular density and greatest vascular caliber — in ‘partial’ response.
- 9 November 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (5) , 45-52
Three-year follow-up study of clinical effectiveness of antiangiogenic therapy for neovascular age-related macular degeneration
ЦЕЛЬ ИССЛЕДОВАНИЯ Анализ клинической эффективности долгосрочной (3 года) анти-VEGF-терапии неоваскулярной возрастной макулярной дегенерации (нВМД) и определение клинически значимых взаимосвязей между функциональными и структурными параметрами. МАТЕРИАЛ И МЕТОДЫ В исследование включено 122 пациента (122 глаза) с диагнозом нВМД, средний возраст — 73,4±6,6 года. Длительность проспективного наблюдения — 144 нед. Все пациенты получали терапию ингибитором ангиогенеза (афлиберцепт 2 мг), в 72,9% случаев — в режиме Treat & Extend (T&E). РЕЗУЛЬТАТЫ Среднее количество инъекций составило 7,39±1,28; 4,63±0,97 и 4,06±0,81 соответственно годам наблюдения. Средняя исходная максимальная корригируемая острота зрения (МКОЗ) — 0,24±0,21. После трех загрузочных инъекций (ЗИ) отмечено повышение МКОЗ до 0,33±0,26 (+0,09; 37,5%), к окончанию наблюдения показатель составил 0,35±0,27 (+0,11; 45,8%). Центральная толщина сетчатки к окончанию наблюдения уменьшилась с 314,89±88,07 до 234,4±42,8 мкм (на 25,5%). После трех ЗИ выявлена наиболее значимая взаимосвязь исходных функциональных и анатомических параметров (с r≥0,7; p<0,05) с наличием интраретинальной жидкости, состоянием эллипсоидной зоны в фовеа и площадью макулярной атрофии. ЗАКЛЮЧЕНИЕ Анализ достигнутых морфофункциональных результатов в течение первого года терапии свидетельствует о возможности их сохранения с уменьшением потребности в визитах и инъекциях при использовании протокола T&E. Достижение максимального повышения функциональных показателей наиболее клинически значимо ассоциировано с динамикой таких биомаркеров, как толщина центральной зоны сетчатки, площадь макулярной атрофии, целостность эллипсоидной зоны.
- 9 November 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (5) , 45-52
Three-year follow-up study of clinical effectiveness of antiangiogenic therapy for neovascular age-related macular degeneration
ЦЕЛЬ ИССЛЕДОВАНИЯ Анализ клинической эффективности долгосрочной (3 года) анти-VEGF-терапии неоваскулярной возрастной макулярной дегенерации (нВМД) и определение клинически значимых взаимосвязей между функциональными и структурными параметрами. МАТЕРИАЛ И МЕТОДЫ В исследование включено 122 пациента (122 глаза) с диагнозом нВМД, средний возраст — 73,4±6,6 года. Длительность проспективного наблюдения — 144 нед. Все пациенты получали терапию ингибитором ангиогенеза (афлиберцепт 2 мг), в 72,9% случаев — в режиме Treat & Extend (T&E). РЕЗУЛЬТАТЫ Среднее количество инъекций составило 7,39±1,28; 4,63±0,97 и 4,06±0,81 соответственно годам наблюдения. Средняя исходная максимальная корригируемая острота зрения (МКОЗ) — 0,24±0,21. После трех загрузочных инъекций (ЗИ) отмечено повышение МКОЗ до 0,33±0,26 (+0,09; 37,5%), к окончанию наблюдения показатель составил 0,35±0,27 (+0,11; 45,8%). Центральная толщина сетчатки к окончанию наблюдения уменьшилась с 314,89±88,07 до 234,4±42,8 мкм (на 25,5%). После трех ЗИ выявлена наиболее значимая взаимосвязь исходных функциональных и анатомических параметров (с r≥0,7; p<0,05) с наличием интраретинальной жидкости, состоянием эллипсоидной зоны в фовеа и площадью макулярной атрофии. ЗАКЛЮЧЕНИЕ Анализ достигнутых морфофункциональных результатов в течение первого года терапии свидетельствует о возможности их сохранения с уменьшением потребности в визитах и инъекциях при использовании протокола T&E. Достижение максимального повышения функциональных показателей наиболее клинически значимо ассоциировано с динамикой таких биомаркеров, как толщина центральной зоны сетчатки, площадь макулярной атрофии, целостность эллипсоидной зоны.
- 1 September 2023
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 13 (3) , 105-115
Current Data on the Age-Related Macular Degeneration Pathophysiology: Focus on Growth Factors and Neurotrophins
Age is a main risk factor for age-related macular degeneration (AMD), a complex multifactorial neurodegenerative retinal disease that is becoming the leading cause of vision loss in people over 55 years in developed countries. The risk of developing and rate of progression of AMD, as well as response to therapy, depend on the interaction of multiple genetic and environmental factors. In advanced stage, AMD is classified into dry atrophic (dry) or neovascular (wet) form. Intravitreal injection of anti-vascular endothelial growth factor agents is currently the first-line therapy for neovascular AMD. Unfortunately, therapy for dry AMD is still challenging, owing to an insufficient knowledge of the exact pathogenetic mechanisms. Considering the heterogeneity of AMD and the complexity of influencing age-dependent physiological processes, aging and immune disorders, the most realistic seems to be the further development of antiangiogenic therapy with an expansion of the range of targets, prolongation of their action and improvement of the delivery system. The neuroprotective potential of exogenous neurotrophins for retinal neurons has been proven; however, in order to develop effective drugs for the dry form of AMD based on them, it is necessary to resolve the issue of ways to effectively deliver them to the retina. In this review we discuss the current data on the AMD pathophysiology with focus on the role of vascular growth factors and neurotrophins.
- 1 September 2023
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 13 (3) , 105-115
Current Data on the Age-Related Macular Degeneration Pathophysiology: Focus on Growth Factors and Neurotrophins
Age is a main risk factor for age-related macular degeneration (AMD), a complex multifactorial neurodegenerative retinal disease that is becoming the leading cause of vision loss in people over 55 years in developed countries. The risk of developing and rate of progression of AMD, as well as response to therapy, depend on the interaction of multiple genetic and environmental factors. In advanced stage, AMD is classified into dry atrophic (dry) or neovascular (wet) form. Intravitreal injection of anti-vascular endothelial growth factor agents is currently the first-line therapy for neovascular AMD. Unfortunately, therapy for dry AMD is still challenging, owing to an insufficient knowledge of the exact pathogenetic mechanisms. Considering the heterogeneity of AMD and the complexity of influencing age-dependent physiological processes, aging and immune disorders, the most realistic seems to be the further development of antiangiogenic therapy with an expansion of the range of targets, prolongation of their action and improvement of the delivery system. The neuroprotective potential of exogenous neurotrophins for retinal neurons has been proven; however, in order to develop effective drugs for the dry form of AMD based on them, it is necessary to resolve the issue of ways to effectively deliver them to the retina. In this review we discuss the current data on the AMD pathophysiology with focus on the role of vascular growth factors and neurotrophins.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (2) , 120-130
New findings on pathogenetic mechanisms in the development of age-related macular degeneration
Возрастная макулярная дегенерация (ВМД) — сложное многофакторное заболевание, возникающее в результате дисфункции и дегенерации ретинального пигментного эпителия (РПЭ), хориокапилляров и гибели фоторецепторов. При этом точный механизм патогенеза остается неизвестным. Старение является наиболее важным и наиболее твердо установленным фактором риска ВМД. Особую роль играет секреторный фенотип старения, распространяющийся от клетки к клетке и опосредованный секрецией и высвобождением факторов роста, цитокинов, хемокинов, протеаз и других молекул, способствующих развитию и прогрессированию заболевания. Также большое значение имеет окислительный стресс, возникающий вследствие нарушения рециркуляции витамина A в зрительном цикле и накопления липофусцина. Последний опосредует образование окислителей с участием железа, оказывающих токсическое действие на митохондрии. Кроме того, развитие воспаления в сетчатке обусловлено длительным воздействием окислительного стресса при постоянных световых воздействиях. Накопление продуктов обмена, а также клеточных дефектов с возрастом может вызывать воспалительную реакцию, которая усиливает уже имеющиеся повреждения. Воспалительные процессы, включая врожденный иммунный ответ, активацию микроглии и паравоспаление, локально происходящие в сосудистой оболочке, РПЭ и нейроретине, чрезвычайно важны для развития возрастных изменений, их прогрессирования до продвинутых стадий ВМД. Особую роль в развитии хориоидальной неоваскуляризации (ХНВ) играют различные факторы роста. Традиционно основным фактором неоангиогенеза и вследствие этого основной терапевтической мишенью считался VEGF-A, однако в последние годы определена роль и ведется активное изучение и других факторов — VEGF-B, -C, -D, PGF, Gal-1, ангиопоэтинов. В статье рассмотрены основные механизмы, влияющие на развитие хориоидальной неоваскуляризации, включая старение сетчатки, нарушение метаболической активности, дисфункцию митохондрий, воспалительные реакции и генетические вариации, а также описана роль различных факторов роста.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (2) , 120-130
New findings on pathogenetic mechanisms in the development of age-related macular degeneration
Возрастная макулярная дегенерация (ВМД) — сложное многофакторное заболевание, возникающее в результате дисфункции и дегенерации ретинального пигментного эпителия (РПЭ), хориокапилляров и гибели фоторецепторов. При этом точный механизм патогенеза остается неизвестным. Старение является наиболее важным и наиболее твердо установленным фактором риска ВМД. Особую роль играет секреторный фенотип старения, распространяющийся от клетки к клетке и опосредованный секрецией и высвобождением факторов роста, цитокинов, хемокинов, протеаз и других молекул, способствующих развитию и прогрессированию заболевания. Также большое значение имеет окислительный стресс, возникающий вследствие нарушения рециркуляции витамина A в зрительном цикле и накопления липофусцина. Последний опосредует образование окислителей с участием железа, оказывающих токсическое действие на митохондрии. Кроме того, развитие воспаления в сетчатке обусловлено длительным воздействием окислительного стресса при постоянных световых воздействиях. Накопление продуктов обмена, а также клеточных дефектов с возрастом может вызывать воспалительную реакцию, которая усиливает уже имеющиеся повреждения. Воспалительные процессы, включая врожденный иммунный ответ, активацию микроглии и паравоспаление, локально происходящие в сосудистой оболочке, РПЭ и нейроретине, чрезвычайно важны для развития возрастных изменений, их прогрессирования до продвинутых стадий ВМД. Особую роль в развитии хориоидальной неоваскуляризации (ХНВ) играют различные факторы роста. Традиционно основным фактором неоангиогенеза и вследствие этого основной терапевтической мишенью считался VEGF-A, однако в последние годы определена роль и ведется активное изучение и других факторов — VEGF-B, -C, -D, PGF, Gal-1, ангиопоэтинов. В статье рассмотрены основные механизмы, влияющие на развитие хориоидальной неоваскуляризации, включая старение сетчатки, нарушение метаболической активности, дисфункцию митохондрий, воспалительные реакции и генетические вариации, а также описана роль различных факторов роста.